Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice
Guidelines for diagnosis, treatment and follow-up

J 2021

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

BOSSI, P., A. T. CHAN, L. LICITRA, A. TRAMA, E. ORLANDI et. al.

Basic information

Original name

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Authors

BOSSI, P. (guarantor), A. T. CHAN, L. LICITRA, A. TRAMA, E. ORLANDI, E. P. HUI, Jana HALÁMKOVÁ (203 Czech Republic, belonging to the institution), S. MATTHEIS, B. BAUJAT, J. HARDILLO, L. SMEELE, C. VAN HERPEN, A. CASTRO and J. P. MACHIELS

Edition

Annals of Oncology, AMSTERDAM, Oxford University Press, 2021, 0923-7534

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30204 Oncology

Country of publisher

Netherlands

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 51.769

RIV identification code

RIV/00216224:14110/21:00122115

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1016/j.annonc.2020.12.007

UT WoS

000629502100007

Keywords in English

nasopharyngeal cancer; Clinical Practice Guidelines; diagnosis; treatment; follow-up

Abstract

V originále

This ESMO-EURACAN Clinical Practice Guideline provides key recommendations for managing nasopharyngeal cancer (NPC). It covers screening, clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up. Treatment algorithms for locoregional and recurrent/metastatic NPC are provided. Recommendations were compiled by the authors based on available scientific data and the authors' collective expert opinion.

Links

LM2018128, research and development project

Name: Český národní uzel Evropské sítě infrastruktur klinického výzkumu (Acronym: CZECRIN)

Investor: Ministry of Education, Youth and Sports of the CR

Citovat

BOSSI, P., A. T. CHAN, L. LICITRA, A. TRAMA, E. ORLANDI, E. P. HUI, Jana HALÁMKOVÁ, S. MATTHEIS, B. BAUJAT, J. HARDILLO, L. SMEELE, C. VAN HERPEN, A. CASTRO and J. P. MACHIELS. Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. AMSTERDAM: Oxford University Press, 2021, vol. 32, No 4, p. 452-465. ISSN 0923-7534. Available from: https://dx.doi.org/10.1016/j.annonc.2020.12.007.

@article{1786779,
   author = {Bossi, P. and Chan, A. T. and Licitra, L. and Trama, A. and Orlandi, E. and Hui, E. P. and Halámková, Jana and Mattheis, S. and Baujat, B. and Hardillo, J. and Smeele, L. and van Herpen, C. and Castro, A. and Machiels, J. P.},
   article_location = {AMSTERDAM},
   article_number = {4},
   doi = {http://dx.doi.org/10.1016/j.annonc.2020.12.007},
   keywords = {nasopharyngeal cancer; Clinical Practice Guidelines; diagnosis; treatment; follow-up},
   language = {eng},
   issn = {0923-7534},
   journal = {Annals of Oncology},
   title = {Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up},
   url = {https://www.sciencedirect.com/science/article/pii/S0923753420432107?via%3Dihub},
   volume = {32},
   year = {2021}
}

TY  - JOUR
ID  - 1786779
AU  - Bossi, P. - Chan, A. T. - Licitra, L. - Trama, A. - Orlandi, E. - Hui, E. P. - Halámková, Jana - Mattheis, S. - Baujat, B. - Hardillo, J. - Smeele, L. - van Herpen, C. - Castro, A. - Machiels, J. P.
PY  - 2021
TI  - Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
JF  - Annals of Oncology
VL  - 32
IS  - 4
SP  - 452-465
EP  - 452-465
PB  - Oxford University Press
SN  - 09237534
KW  - nasopharyngeal cancer
KW  - Clinical Practice Guidelines
KW  - diagnosis
KW  - treatment
KW  - follow-up
UR  - https://www.sciencedirect.com/science/article/pii/S0923753420432107?via%3Dihub
N2  - This ESMO-EURACAN Clinical Practice Guideline provides key recommendations for managing nasopharyngeal cancer (NPC). It covers screening, clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up. Treatment algorithms for locoregional and recurrent/metastatic NPC are provided. Recommendations were compiled by the authors based on available scientific data and the authors' collective expert opinion.
ER  -

BOSSI, P., A. T. CHAN, L. LICITRA, A. TRAMA, E. ORLANDI, E. P. HUI, Jana HALÁMKOVÁ, S. MATTHEIS, B. BAUJAT, J. HARDILLO, L. SMEELE, C. VAN HERPEN, A. CASTRO and J. P. MACHIELS. Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. \textit{Annals of Oncology}. AMSTERDAM: Oxford University Press, 2021, vol.~32, No~4, p.~452-465. ISSN~0923-7534. Available from: https://dx.doi.org/10.1016/j.annonc.2020.12.007.

Detailed Information on Publication Record